Cite
HARVARD Citation
Echevarría‐Vargas, I. et al. (2018). Co‐targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor‐resistant melanoma. EMBO molecular medicine. 10 (5), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Echevarría‐Vargas, I. et al. (2018). Co‐targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor‐resistant melanoma. EMBO molecular medicine. 10 (5), p. n/a. [Online].